Table 1.

High sensitivity NGS analysis of whole tumor sections before immunotherapy.

	Mutations	Frequency	Molecular Depth	Tumor Cell Content	Comment
Patient 1	KRAS p.G12R NRAS p.Q61R NRAS p.G12V	4.6% 3.27% 7.04%	913x 765x 270x	40%	KIT not covered by the assay
Patient 2	KRAS p.G12A	64.21%	992x	70%
Patient 3	WT			30%

WT = wild type.